(Q46670471)

English

Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801.

scientific article published on 17 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

Atypical antipsychotics and a Src kinase inhibitor (PP1) prevent cortical injury produced by the psychomimetic, noncompetitive NMDA receptor antagonist MK-801. (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

author name string

Jon Dickerson

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

Frank R Sharp

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

language of work or name

0 references

publication date

17 August 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

Neuropsychopharmacology

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

31

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

1420-1430

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300878

0 references

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Src family kinase inhibitor PP1 reduces secondary damage after spinal cord compression in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Acute behavioral effects of MK-801 in the mouse.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Parallel recovery of MK-801-induced spatial learning impairment and neuronal injury in male mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

State-related changes in cerebral white matter may underlie psychosis exacerbation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Muscimol prevents NMDA antagonist neurotoxicity by activating GABAA receptors in several brain regions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Altered metabolic activity in the cerebral cortex of rats exposed to ketamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Tyrosine phosphorylation and regulation of the AMPA receptor by SRC family tyrosine kinases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Interactions between Src family protein tyrosine kinases and PSD-95

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

NMDA receptor hypofunction model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Acute phencyclidine neurotoxicity in rat forebrain: induction of haem oxygenase-1 and attenuation by the antioxidant dimethylthiourea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Src kinases: a hub for NMDA receptor regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Phencyclidine induction of the hsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Heat shock proteins used to show that haloperidol prevents neuronal injury produced by ketamine, MK801, and phencyclidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Heat-shock protein protection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Dimethylsulfoxide (DMSO) treatment reduces infarction volume after permanent focal cerebral ischemia in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Selection of atypical antipsychotics for the management of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Pharmacological profile of neuroleptics at human monoamine transporters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

21 January 2018

Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed regional metabolic actions of phencyclidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

7 January 2021

based on heuristic

inferred from DOI database lookup

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebellar toxicity of phencyclidine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

7 January 2021

based on heuristic

inferred from DOI database lookup

Peptides and psychiatry, Part 1: How synthesis of neuropeptides differs from classical neurotransmitter synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoxetine prevents PCP- and MK801-induced HSP70 expression in injured limbic cortical neurons of rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300878

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300878

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16123741

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46670471&oldid=1466198521"